Page 3 - பிரிவு ஆஃப் புற்றுநோய் உயிரியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பிரிவு ஆஃப் புற்றுநோய் உயிரியல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பிரிவு ஆஃப் புற்றுநோய் உயிரியல் Today - Breaking & Trending Today

NCI Deputy Director Dinah Singer, Ph.D.


Dinah Singer, Ph.D.
NCI Deputy Director for Scientific Strategy and Development
As the National Cancer Institute’s (NCI) deputy director for scientific strategy and development, Dinah Singer, Ph.D., works closely with the NCI director and other deputy directors to carry out the institute’s mission. Prior to taking on this role in 2019, she served as director of NCI’s Division of Cancer Biology (DCB), a position she held for 20 years. 
As deputy director, Dr. Singer leads a number of key initiatives at NCI. In early 2020, as part of NCI’s response to the COVID-19 pandemic, she led the rapid creation of the Serological Sciences Network (SeroNet) to expand serological testing capacity and research to characterize the immune responses elicited by the SARS-CoV-2 viral infection. ....

United States , United Kingdom , Center To Reduce Cancer Health Disparities , National Cancer Institute , Division Of Cancer Biology , Laboratory Of Biochemistry , Cancer Research , Research Strategy , Common Fund , Research Specialist Award , Massachusetts Institute Of Technology , Columbia University , Experimental Immunology Branch , American Association Of Immunologists , American Association For Cancer Research , Cancer Research United Kingdom , Serological Sciences Network Seronet , Immunology Branch , Blue Ribbon Panel , Dinah Singer , Scientific Strategy , Cancer Biology , Strategic Scientific Initiatives , Reduce Cancer Health Disparities , Serological Sciences Network , Cancer Moonshot ,

Researchers find new method for safe and effective delivery of medicines to the lungs


Researchers find new method for safe and effective delivery of medicines to the lungs
Investigators at Rutgers Cancer Institute of New Jersey and Rutgers New Jersey Medical School recently identified a new method for safe and effective delivery of medicines to the lungs that can be used for multiple clinical applications, potentially including aerosol vaccination. The results of the study will be published online ahead of print in the December issue of
Med (10.1016/j.medj.2020.10.005).
Targeted pulmonary delivery may have many conceptual advantages over other routes of vaccine administration and therapeutics, particularly for certain respiratory infections (including but not limited to SARS-CoV-2) because they arrive directly at the site of the infection. ....

Danielai Staquicini , Renata Pasqualini , Emily Henderson , Rutgers New Jersey Medical School , Division Of Cancer Biology , Rutgers Cancer Institute , New Jersey , Cancer Biology , Radiation Oncology , Rutgers New Jersey Medical , Wadih Arap , University Hospital , ரெனாட்டா பாஸ்குவாலீநீ , எமிலி ஹென்டர்சன் , ரட்ஜர்ஸ் புதியது ஜெர்சி மருத்துவ பள்ளி , பிரிவு ஆஃப் புற்றுநோய் உயிரியல் , ரட்ஜர்ஸ் புற்றுநோய் நிறுவனம் , புதியது ஜெர்சி , புற்றுநோய் உயிரியல் , கதிர்வீச்சு புற்றுநோயியல் , ரட்ஜர்ஸ் புதியது ஜெர்சி மருத்துவ , பல்கலைக்கழகம் மருத்துவமனை ,

PhageNova Bio, Inc. Announces Publication Describing Identification of a Safe and Effective Method of Delivering Medicines to the Lungs


Published: Dec 10, 2020
 
NEW YORK, Dec. 10, 2020 /PRNewswire/  PhageNova Bio, Inc. ( PhageNova ) is pleased to announce the publication of data generated through a sponsored research agreement with Rutgers, The State University of New Jersey. The
Med (a
Cell Press publication) article, entitled
Targeted Phage Display-Based Pulmonary Vaccination in Mice and Non-human Primates, describes a new method for safe and effective pulmonary delivery of therapeutics, including an aerosol vaccination strategy which is being developed to address the current SARS-CoV-2 pandemic.
Our targeted method of pulmonary delivery is the initial step towards the development of aerosol phage-based vaccines for human applications against multiple diseases, says Renata Pasqualini, PhD, co-senior study author, Founder and Chief Scientific Officer of PhageNova, and Chief of the Division of Cancer Biology, Department of Radiation Oncology at Rutgers Cancer Institute and Rut ....

New Jersey , United States , Jason Rifkin , Renata Pasqualini , Phagenova Bio , University Of New Jersey , Division Of Cancer Biology , Rutgers New Jersey Medical School , Rutgers Cancer Institute , Aa Cell , Phagenova Bio Inc , State University , Cell Press , Non Human Primates , Chief Scientific Officer , Cancer Biology , Radiation Oncology , Rutgers New Jersey Medical , Wadih Arap , University Hospital , Nova Bio , புதியது ஜெர்சி , ஒன்றுபட்டது மாநிலங்களில் , ஜேசன் ரிஃப்கின் , ரெனாட்டா பாஸ்குவாலீநீ , பல்கலைக்கழகம் ஆஃப் புதியது ஜெர்சி ,